Epididymal secretion of CD52 as measured in human seminal plasma by a fluorescence immunoassay.

Abstract

A major secretory protein of the human epididymis that is taken up by maturing spermatozoa is homologous to the leukocyte antigen CD52. The epididymis was shown to be the sole source of CD52 in seminal fluid, since CD52 could be detected in seminal plasma from sperm-containing ejaculates and not in ejaculates of vasectomized patients by Western blot analysis. The glycoprotein is not expressed in the testes. A fluorescence immunobinding assay was developed to quantify the amount of epididymal secretion of CD52 in the seminal plasma of various groups of fertile and infertile patients. Donor spermatozoa bearing CD52 were used as binding site tracers for free anti-CD52 antibody remaining after it had adsorbed CD52 from the seminal plasma to be assayed. The level of subsequent antibody binding to spermatozoa was measured by flow cytometry and the extent of binding inhibition was compared to a reference pool of seminal plasma to provide relative amounts of CD52 in test seminal plasma. There were no correlations between seminal plasma CD52 concentration and any semen parameter tested, including sperm concentration, percentage motility, normal sperm morphology or the concentration of seminal neutral alpha-glucosidase, fructose and zinc. There was a slight tendency towards an inverse relationship with the amount of CD52 on spermatozoa, but this was not significant. No differences were found among groups of patients classified by their semen parameters or fertility status. These findings indicate that the epididymal specific supply of CD52 is not a limiting factor for CD52 uptake onto spermatozoa.